|
000
| 01796nam 2200325zi 4500 |
|---|
| 001 | 9.932478 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240220145609 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 240115s201306 onc ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-531/2013E-PDF |
|---|
| 245 | 00|aSummative evaluation of the Bovine Spongiform Encephalopathy (BSE) I and II initiatives / |cprepared by Evaluation Directorate, Health Canada and the Public Health Agency of Canada. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cJune 2013. |
|---|
| 300 | |a1 online resource (x, 82 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Évaluation sommative des initiatives de l’encéphalopathie spongiforme bovine (ESB) I et II. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aBovine spongiform encephalopathy|zCanada|xSafety measures|xEvaluation. |
|---|
| 650 | 0|aHealth risk assessment|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tÉvaluation sommative des initiatives de l’encéphalopathie spongiforme bovine (ESB) I et II / |w(CaOODSP)9.934180 |
|---|
| 856 | 40|qPDF|s1.45 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-531-2013-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/about-health-canada/accountability-performance-financial-reporting/evaluation-reports/summative-evaluation-bovine-spongiform-encephalopathy-initiatives-acronyms.html |
|---|